Maintaining GLP-1 Weight Loss Through Body Devices
Dr Marwa Ali examines the role of body devices in GLP-1–associated weight loss The use of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and tirzepatide, has grown rapidly in medical weight management.¹ With patients achieving significant weight loss and …
To access this post, you must purchase Aesthetics Journal Membership – Annual Elite Membership, Aesthetics Journal Membership – Annual Enhanced Membership or Aesthetics Journal Membership – Basic Membership.
log in
log in